Roman Yelensky serves as Executive at Gritstone Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Roman Yelensky has executed 5 insider transactions totaling $442.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 8, 2021 involved exercising options for 50,724 shares valued at $38.6K.
Roman Yelensky currently holds 234,672 shares of Gritstone Oncology, Inc. (GRTS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Roman Yelensky has been a net seller of GRTS stock. They have purchased $0 and sold $442.0K worth of shares.
Roman Yelensky's most recent insider trade was on Mar 8, 2021, when they sold 50,724 shares at $0.76 per share.
Get notified when new Form 4 filings are submitted
| 50,724 |
| $0.76 |
| Discretionary |
| Jan 19, 2021 | GRTS | $221.0K | Sale | 10,000 | $22.10 | Discretionary |
| Jan 19, 2021 | GRTS | $221.0K | Sale | 10,000 | $22.10 | Discretionary |
| Jan 7, 2021 | GRTS | $0 | Award | 27,400 | $N/A | Discretionary |